
An FDA advisory committee has said that the labels of two type 2 diabetes drugs should be changed to warn …

AstraZeneca’s diabetes drug Onglyza may lead to a ‘significant increase’ in risk of death according to a new analysis from …

Takeda has been given US approval for its diabetes drug Nesina and two variations on it for the treatment of …
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ

